Re: Malte Rieken, Shahrokh F. Shariat, Luis A. Kluth, et al. Association of Cigarette Smoking and Smoking Cessation with Biochemical Recurrence of Prostate Cancer in Patients Treated with Radical Prostatectomy. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2015.05.038

被引：1

作者：

Froehner, Michael ^{[1
]}

Koch, Rainer ^{[2
]}

Wirth, Manfred P. ^{[1
]}

机构：

[1] Tech Univ Dresden, Dept Urol, Univ Hosp Carl Gustav Carus, D-01307 Dresden, Germany

[2] Tech Univ Dresden, Dept Med Stat & Biometry, Univ Hosp Carl Gustav Carus, D-01307 Dresden, Germany

来源：

EUROPEAN UROLOGY | 2015年 / 68卷 / 05期

关键词：

D O I：

10.1016/j.eururo.2015.08.011

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：E103 / E103

页数：1

共 50 条

[31] Reply to Glen Denmer Santok and Koon Ho Rha's Letter to the Editor re: Par Stattin, Fredrik Sandin, Frederik Birkebaek Thomsen, et al. Association of Radical Local Treatment with Mortality in Men with Very High-risk Prostate Cancer: A Semiecologic, Nationwide, Population-based Study. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2016.07.023
Stattin, Par
Bratt, Ola
[J]. EUROPEAN UROLOGY, 2017, 71 (04) : E115 - E116
[32] Re: Bernardo Rocco, Luca Sarchi, Simone Assumma, et al. Digital Frozen Sections with Fluorescence Confocal Microscopy During Robot-assisted Radical Prostatectomy: Surgical Technique. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2021.03.021
Dinneen, Eoin
Oxley, Jon
Shaw, Greg
[J]. EUROPEAN UROLOGY, 2021, 80 (05) : E120 - E121
[33] Re: Michael Baboudjian, Romain Diamand, Alessandro Uleri, et al. Does Overgrading on Targeted Biopsy of Magnetic Resonance Imaging-visible Lesions in Prostate Cancer Lead to Overtreatment? Eur Urol. In press. https://doi.org/10.1016/j.eururo.2024.02.003
Vickers, Andrew J.
[J]. EUROPEAN UROLOGY, 2024, 86 (03) : e71 - e71
[34] Re: Helene Hartvedt Grytli, Morten Wang Fagerland, Sophie D. Fossa, Kristin Austlid Tasken. Association Between Use of β-Blockers and Prostate Cancer-specific Survival: A Cohort Study of 3561 Prostate Cancer Patients with High-risk or Metastatic Disease. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2013.01.007.
Bhaskaran, Krishnan
Rachet, Bernard
Evans, Stephen
Smeeth, Liam
[J]. EUROPEAN UROLOGY, 2013, 64 (04) : E86 - E87
[35] Reply to Bhupendra Pal Singh and Urmila Dhakad's Letter to the Editor re: Beat Roth, Frederic D. Birkhauser, Pascal Zehnder, et al. Parenteral Nutrition Does Not Improve Postoperative Recovery from Radical Cystectomy: Results of a Prospective Randomised Trial. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2012.05.052
Studer, Urs E.
[J]. EUROPEAN UROLOGY, 2012, 62 (04) : E80 - E80
[36] Re: Helene Hartvedt Grytli, Morten Wang Fagerland, Sophie D. Fossa, Kristin Austlid Tasken. Association Between Use of β-Blockers and Prostate Cancer-specific Survival: A Cohort Study of 3561 Prostate Cancer Patients with High-risk or Metastatic Disease. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2013.01.007
Cardwell, Chris R.
Suissa, Samy
Murray, Liam J.
[J]. EUROPEAN UROLOGY, 2013, 64 (01) : E10 - E10
[37] Re: Christina G. Jespersen, Mette Norgaard, Michael Borre. Androgen-deprivation Therapy in Treatment of Prostate Cancer and Risk of Myocardial Infarction and Stroke: A Nationwide Danish Population-based Cohort Study. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2013.02.002
Schooling, C. Mary
Sembajwe, Grace
Agalliu, Ilir
[J]. EUROPEAN UROLOGY, 2013, 64 (03) : E59 - E60
[38] Re: Michal Sarfaty, Moshe Leshno, Noa Gordon, et al. Cost Effectiveness of Nivolumab in Advanced Renal Cell Carcinoma. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2017.07.041 Second-line Treatment in Metastatic Renal Cell Carcinoma. Can Immunotherapy Be Considered a Cost-effective Treatment?
Giuliani, Jacopo
Bonetti, Andrea
[J]. EUROPEAN UROLOGY, 2018, 73 (03) : E74 - E74
[39] Re: Grant D. Stewart, Fiach C. O'Mahony, Alexander Laird, et al. Carbonic Anhydrase 9 Expression Increases with Vascular Endothelial Growth Factor-Targeted Therapy and Is Predictive of Outcome in Metastatic Clear Cell Renal Cancer. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2014.04.007
Kroeger, Nils
Pantuck, Allan J.
[J]. EUROPEAN UROLOGY, 2014, 66 (04) : E69 - E70
[40] Re: Floris H. Groenendijk, Jeroen de Jong, Elisabeth E. Fransen van de Putte, et al. ERBB2 Mutations Characterize a Subgroup of Muscle-invasive Bladder Cancers with Excellent Response to Neoadjuvant Chemotherapy. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2015.01.014
Van Allen, Eliezer M.
Garraway, Levi A.
Rosenberg, Jonathan E.
[J]. EUROPEAN UROLOGY, 2015, 68 (02) : E31 - E32

← 1 2 3 4 5 →